Interesting DNDN Put And Call Options For February 2015

Investors in Dendreon Corp ( DNDN) saw new options begin trading this week, for the February 2015 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new February 2015 contracts and identified one put and one call contract of particular interest.

The put contract at the $1.50 strike price has a current bid of 28 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $1.50, but will also collect the premium, putting the cost basis of the shares at $1.22 (before broker commissions). To an investor already interested in purchasing shares of DNDN, that could represent an attractive alternative to paying $2.05/share today.

Because the $1.50 strike represents an approximate 27% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 79%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 18.67% return on the cash commitment, or 28.38% annualized — at Stock Options Channel we call this the YieldBoost.

Top YieldBoost Puts of the S&P 500 »

Below is a chart showing the trailing twelve month trading history for Dendreon Corp, and highlighting in green where the $1.50 strike is located relative to that history:

If you liked this article you might like

Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

Nominees for Absolute Worst Biotechnology CEOs of 2014 Are ...

Using Re-Engineered Immune Cells to Kill Leukemia Induces Lasting Remissions

Stock Market Today: S&P 500 Eyes Strong Finish for 2014; Alibaba Spikes